Aspirin → HCID 62705023, 화합물
반응식
[CH3:1][CH:2]([CH3:33])[C:3]1[N:4]=[C:5]([N:27]([CH3:32])[S:28]([CH3:31])(=[O:30])=[O:29])[N:6]=[C:7]([C:20]2[CH:25]=[CH:24][C:23]([F:26])=[CH:22][CH:21]=2)[C:8]=1/[CH:9]=[CH:10]/[C@H:11]([CH2:13][C@H:14]([CH2:16][C:17]([O-:19])=[O:18])[OH:15])[OH:12].[CH3:34][CH:35]([CH3:66])[C:36]1[N:37]=[C:38]([N:60]([CH3:65])[S:61]([CH3:64])(=[O:63])=[O:62])[N:39]=[C:40]([C:53]2[CH:58]=[CH:57][C:56]([F:59])=[CH:55][CH:54]=2)[C:41]=1/[CH:42]=[CH:43]/[C@H:44]([CH2:46][C@H:47]([CH2:49][C:50]([O-:52])=[O:51])[OH:48])[OH:45].[Ca+2:67].[CH3:68][C:69]([O:71][C:72]1[CH:73]=[CH:74][CH:75]=[CH:76][C:77]=1[C:78]([OH:80])=[O:79])=[O:70]>C(O)C>[CH3:1][CH:2]([CH3:33])[C:3]1[N:4]=[C:5]([N:27]([CH3:32])[S:28]([CH3:31])(=[O:29])=[O:30])[N:6]=[C:7]([C:20]2[CH:21]=[CH:22][C:23]([F:26])=[CH:24][CH:25]=2)[C:8]=1/[CH:9]=[CH:10]/[C@H:11]([CH2:13][C@H:14]([CH2:16][C:17]([O-:19])=[O:18])[OH:15])[OH:12].[CH3:34][CH:35]([CH3:66])[C:36]1[N:37]=[C:38]([N:60]([CH3:65])[S:61]([CH3:64])(=[O:62])=[O:63])[N:39]=[C:40]([C:53]2[CH:54]=[CH:55][C:56]([F:59])=[CH:57][CH:58]=2)[C:41]=1/[CH:42]=[CH:43]/[C@H:44]([CH2:46][C@H:47]([CH2:49][C:50]([O-:52])=[O:51])[OH:48])[OH:45].[Ca+2:67].[CH3:68][C:69]([O:71][C:72]1[CH:73]=[CH:74][CH:75]=[CH:76][C:77]=1[C:78]([OH:80])=[O:79])=[O:70]참가 물질
4
반응 조건
- 온도
- 140 °C
실험 절차
The highly non-crystalline glass state of the combination of rosuvastatin calcium and aspirin was produced by applying a repeated sequence of short wavelength followed by long wavelength laser light modulated and structured by a Strachan Device. A 60 mg sample of rosuvastatin calcium and a 60 mg sample of crystalline aspirin were dissolved in 1200 mg of absolute ethanol by stirring at 9000 rpm with a magnetic stirrer, while heating to 140° C. for 10 minutes in a stoppered Erlenmeyer flask. The solution was filtered, and then divided equally into 6 polystyrene Petri dishes for producing treated and untreated control samples and each sample was covered with a polystyrene lid. The samples were allowed to cool to room temperature.